منابع مشابه
Metabolic Fate of Chylomicron
Received for publication 28 October 1978 and in revised form 2 April 1979. I. Clin. Invest. t The American Societu for Clinical Investi-a jection of 250 mg of human or rat intestinal chylomicrons into the rat, there was a significant increase in HDL apoA-I that resulted from acquisition of a major fraction of the chylomicron apoA-I. After injection of chylomicrons, phospholipid vesicles were ob...
متن کاملFate of metabolic hydrogen in the rumen.
Introduction T h e first axiom of ruminology appears to be: ‘The rumen is a strictly anaerobic system’ (Hungate, 1966) but before we accept this we should examine the evidence for and against this assertion. Probably the strongest evidence for anaerobiosis comes from the studies of the reactions in the rumen, from the stoichiometries observed and from the low oxidation-reduction potential obtai...
متن کاملThe metabolic fate and elimination of streptozotocin.
sterone or [16B-”H]betamethasone was given at a dose of 0.23pmol/kg body wt. by intraperitoneal or intravenous route, and bile samples were collected at 30min intervals. In some experiments the animals were pretreated with daily doses (100mg/kg body wt., intraperitoneally) of phenobarbital for 3 consecutive days. In the isolated-liver perfusion experiments tissue-culture medium 199 (100ml) cont...
متن کاملCarbon-fate maps for metabolic reactions
MOTIVATION Stable isotope labeling of small-molecule metabolites (e.g. (13)C-labeling of glucose) is a powerful tool for characterizing pathways and reaction fluxes in a metabolic network. Analysis of isotope labeling patterns requires knowledge of the fates of individual atoms and moieties in reactions, which can be difficult to collect in a useful form when considering a large number of enzym...
متن کاملThe antinociceptive effect of esmolol
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. CC Esmolol is the first intravenous, short-acting, titratable β-blocker available for use...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Drug Metabolism and Pharmacokinetics
سال: 2001
ISSN: 0916-1139
DOI: 10.2133/dmpk.16.415